Psilocybin vs Escitalopram for Major Depressive Disorder: Comparative Mechanisms

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2019
This is a randomised double-blind clinical trial. The aim is to compare the efficacy and mechanisms of action of psilocybin, the primary psychoactive substance in \'magic mushrooms\', with the SSRI (selective serotonin reuptake inhibitor) escitalopram for major depressive disorder (MDD).
Epistemonikos ID: 63988e226c7d09bab471927e4606eb5b031df267
First added on: May 21, 2024